 |
Human Allogeneic HLA-matched, Umbilical Cord Blood Hematopoietic Progenitor Cells Ex Vivo Expanded on Allogeneic Mesenchymal Precursor Cells |
|---|---|
| Trade Name | |
| Orphan Indication | Insufficient hematopoietic stem cell production in patients with hematologic malignancies who have failed treatment with conventional chemotherapy |
| USA Market Approval | USA |
| USA Designation Date | 2008-09-12 00:00:00 |
| Sponsor | Mesoblast, Inc.;275 Madison Avenue, 4th Floor;New York, New York, 10016 |
